BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32643846)

  • 1. Inhibiting microRNA-301b suppresses cell growth and targets RNF38 in cervical carcinoma.
    Guo WL; Li N; Ma JL; Chen XM; Shi FY
    Kaohsiung J Med Sci; 2020 Nov; 36(11):878-884. PubMed ID: 32643846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma.
    Song TT; Xu F; Wang W
    Kaohsiung J Med Sci; 2020 Jul; 36(7):501-507. PubMed ID: 32196955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIR31HG exhibits oncogenic property and acts as a sponge for miR-361-3p in cervical carcinoma.
    Li Y
    Biochem Biophys Res Commun; 2020 Sep; 529(4):890-897. PubMed ID: 32819595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
    Wang D; Wang H; Li Y; Li Q
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).
    Shi X; Xiao X; Yuan N; Zhang S; Yuan F; Wang X
    Oncol Res; 2018 Aug; 26(7):987-996. PubMed ID: 29295725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-532-5p is a prognostic marker and inhibits the aggressive phenotypes of osteosarcoma through targeting CXCL2.
    Ma Y; Zhao HX; Shi YJ; Cheng MG
    Kaohsiung J Med Sci; 2020 Nov; 36(11):885-894. PubMed ID: 32643867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
    Zhang JF
    Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.
    Song Y; Guo Q; Gao S; Hua K
    Biochem Biophys Res Commun; 2019 Aug; 516(3):872-879. PubMed ID: 31270028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2.
    Gao F; Wu H; Wang R; Guo Y; Zhang Z; Wang T; Zhang G; Liu C; Liu J
    Bioengineered; 2019 Dec; 10(1):1-12. PubMed ID: 30836864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
    Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma--relationship with prognosis.
    Wang L; Wang Q; Li HL; Han LY
    Asian Pac J Cancer Prev; 2013; 14(3):2113-8. PubMed ID: 23679328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique microRNA expression profiles in cervical cancer.
    Gocze K; Gombos K; Juhasz K; Kovacs K; Kajtar B; Benczik M; Gocze P; Patczai B; Arany I; Ember I
    Anticancer Res; 2013 Jun; 33(6):2561-7. PubMed ID: 23749909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-96-5p Facilitates the Viability, Migration, and Invasion and Suppresses the Apoptosis of Cervical Cancer Cells byNegatively Modulating SFRP4.
    Zhang H; Chen R; Shao J
    Technol Cancer Res Treat; 2020; 19():1533033820934132. PubMed ID: 32527205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
    Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R
    J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
    Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
    World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.